New Jersey Opioid Reports Expose a Larger Test of Settlement Accountability

New Jersey requires local governments to report opioid-settlement spending, but missing reports, unclear answers and disputed expenditures are raising questions about whether public reporting alone provides meaningful accountability.

Screenshot-style graphic representing New Jersey’s opioid-settlement funding dashboard.

FEATURED IMAGE CREDIT: State of New Jersey opioid-settlement website.
Screenshot-style graphic representing New Jersey’s opioid-settlement funding dashboard. FEATURED IMAGE CREDIT: State of New Jersey opioid-settlement website.
EmergencyIf someone may be experiencing an overdose or immediate danger, call 911. Do not rely on this website for emergency assistance.
Update or correctionClaims involving specific local expenditures are attributed to the New Jersey Monitor investigation and advocates. They are not presented as final legal findings.

New Jersey’s opioid-settlement reports are providing the public with an unusual window into local spending. They are also revealing how disclosure requirements can fall short when reports are incomplete, unclear or not independently reviewed.

New Jersey and its local governments are expected to receive more than $1.1 billion through 2038 from resolved settlements involving opioid manufacturers, distributors and retailers.

The state receives approximately half of the money. The other half is allocated directly to 262 participating local entities, including all 21 counties and qualifying municipalities.

Under the state’s framework, local governments must report how much they received and spent, whether spending involved approved opioid-abatement uses, how decisions were made and whether the public participated.

Those reports are published on the state’s opioid-settlement website.

A November 16 New Jersey Monitor investigation described missing reports, vague responses and expenditures that advocates allege were unsupported or unrelated to direct opioid remediation. The article also documented disagreement between state agencies about responsibility for monitoring local spending.

The claims concerning individual municipalities remain allegations or reported findings unless confirmed through an audit, enforcement action or adjudication. However, the underlying accountability problem is broader: a report is useful only if it is complete, accurate, reviewable and connected to corrective action.

WHAT LOCAL GOVERNMENTS ARE REQUIRED TO REPORT

New Jersey’s annual reporting system asks counties and municipalities to identify receipts, expenditures, administrative costs, public engagement and program details.

Settlement agreements generally require at least 85% of funds to support opioid remediation. New Jersey’s state-local agreement also says settlement funds should supplement rather than replace existing spending and requires records to be retained.

Those are meaningful safeguards.

The reporting system allows residents, journalists, treatment providers and recovery organizations to see information that might otherwise remain buried in local budgets.

Transparency can reveal strong investments as well as weak ones. Communities can compare treatment expansion, naloxone distribution, recovery housing, prevention, outreach, transportation, peer services and administrative spending.

The presence of reports does not prove that every expenditure was compliant or effective. It does give the public a starting point.

ALLEGATIONS RAISED BY THE INVESTIGATION

The New Jersey Monitor reported that Lakewood did not submit its current report on time despite receiving nearly $1.2 million since 2022. A previous response reportedly included vague statements regarding decision-making and public involvement.

The article also described claims by citizen researcher Joe Junfola that approximately 20 municipalities reported almost $2 million for programs or expenses he could not substantiate through receipts or contracts.

Among the disputed examples were surveillance cameras, police vehicles, salaries and equipment. Some officials did not respond to the publication’s requests for comment.

These claims should not be treated as final determinations of fraud. Documents can be incomplete, records can be produced later and legal interpretations may differ.

They are nevertheless serious enough to justify independent examination. Opioid-settlement money is restricted public money tied to an extraordinary health crisis. A government should be able to show what it purchased, why the expenditure qualifies, who benefited and what result was expected.

THE OVERSIGHT GAP

The Monitor described disagreement over which state office must actively monitor municipal spending.

The Department of Human Services collects and publishes reports. A DHS representative reportedly said the Office of the State Comptroller is responsible for oversight. The comptroller’s office responded that state law identifies DHS as the lead monitoring agency.

That kind of divided responsibility creates risk. A county or municipality may technically submit a report without anyone determining whether the answers are consistent, supported by records or connected to approved uses.

Collection is not the same as verification.

A mature oversight system should identify missing reports automatically, require corrections, compare expenditures with source documents, flag unusual spending and publish the resolution of each issue.

WHY OUTCOME MEASUREMENT MATTERS

Even fully documented spending can be ineffective.

A jurisdiction may comply with reporting rules while funding a program that reaches few people, duplicates another service or measures only activity rather than recovery outcomes.

Counting brochures, event attendees or naloxone kits is useful, but it does not always show whether a program reduced overdose, increased treatment entry or helped people remain housed and engaged in recovery.

Good settlement reporting should include both financial accountability and performance information.

For treatment investments, useful measures might include:

  • Number of people assessed and admitted
  • Time from referral to treatment
  • Treatment retention
  • Medication continuation
  • Connections after emergency-department discharge
  • Housing stability
  • Employment or education engagement
  • Nonfatal overdose
  • Repeated emergency utilization
  • Patient-reported recovery and quality of life

No single measure captures recovery. A balanced group of measures can show whether money is producing meaningful benefit.

PUBLIC PARTICIPATION SHOULD OCCUR BEFORE SPENDING

Annual reporting frequently tells residents what happened after decisions were made.

Communities should also have a structured voice before money is committed.

People with lived experience can identify barriers that may not appear in agency plans. They may know that a county has treatment beds but lacks transportation, that recovery housing excludes people taking medication, or that families cannot obtain help after normal office hours.

Treatment providers can identify capacity gaps. Emergency departments can describe failed handoffs. Employers can explain workforce needs. Harm-reduction organizations can identify changing drug-supply conditions.

Public participation should be accessible and documented. A meeting scheduled during work hours with little notice is not meaningful engagement merely because the door was technically open.

LESSONS FROM THE TOBACCO SETTLEMENT

The New Jersey Monitor cited a Princeton researcher who warned that only a small portion of earlier tobacco-settlement payments ultimately funded tobacco-related public-health interventions.

The comparison is important. Settlement payments can gradually become treated as ordinary revenue, especially when local governments face competing budget pressures.

Opioid settlements were negotiated with explicit remediation purposes. Allowing them to become a substitute for routine budgets would weaken the opportunity to build treatment, prevention and recovery infrastructure.

The money will arrive over many years. That creates an opportunity for sustained investment—but also means weak practices can become normalized if they are not corrected early.

Why This Matters

Settlement funds are not simply grants. They represent an attempt to repair a portion of the damage caused by the opioid crisis.

Every dollar spent without documentation is a dollar that cannot be confidently connected to treatment, recovery support, prevention or overdose reduction.

Accountability also protects legitimate programs. When controversial expenditures dominate headlines, the public may begin to distrust all settlement spending. Clear reporting allows effective providers and local governments to demonstrate that their work is real and measurable.

Addiction Recovery Pro Perspective

Addiction Recovery Pro supports public opioid-settlement trackers because transparency can turn fragmented government reports into understandable community information.

But a tracker should never imply certainty that the source documents do not contain. ARP will distinguish reported spending from independently verified outcomes, proposals from final awards and allegations from confirmed findings.

We believe every settlement record should answer five plain-language questions:

  1. How much money was received?
  2. What exactly was purchased or funded?
  3. Which approved purpose does it serve?
  4. Who was expected to benefit?
  5. What result will be measured?

If officials cannot answer those questions, the record is not ready to be described as accountable spending.

ARP also believes oversight should be corrective, not merely punitive. Smaller municipalities may need technical assistance to follow complex rules. The goal should be accurate reporting, compliant investment and better results—not paperwork for its own sake.

BROADER RECOVERY IMPACT:

New Jersey’s experience is a national warning and a national opportunity.

Thousands of local governments across the country are making separate decisions about settlement money. Without consistent definitions, communities cannot easily compare investments or identify successful models.

Public reporting can help recovery organizations locate funding, form partnerships and advocate for unmet needs. It can also reveal geographic inequities in which some communities build long-term treatment capacity while others spend primarily on one-time events or general government functions.

Greater accountability can move the national conversation from “Where did the money go?” to “What improved because the money was spent?”

WHAT FAMILIES SHOULD KNOW:

Residents have the right to review New Jersey’s published county and municipal reports.

If a report is missing or unclear, families can contact local officials, request supporting records and ask how people with lived experience were included.

Suspected fraud, waste or abuse can be reported to the New Jersey Office of the State Comptroller through its online form, comptrollertips@osc.nj.gov or 1-855-OSC-TIPS.

WHAT PROVIDERS SHOULD KNOW:

Providers receiving settlement money should retain contracts, invoices, service totals, referral information and outcome documentation.

Do not wait until the annual report is due to decide what data to collect.

Organizations seeking future funding should explain the local need, proposed intervention, target population, measurable outcomes and plan for sustainability after settlement funding ends.

WHAT ARP WILL WATCH NEXT:

ARP will watch for late reports, corrected filings, audits, enforcement actions, legislative changes and clearer division of responsibility between state agencies.

We will also watch whether New Jersey standardizes program descriptions and outcome reporting across municipalities.

Treatment options in this location

Explore addiction treatment options in New Jersey.

Original sources

Explore Treatment and Recovery Resources

Search licensed treatment facilities and recovery support by state and city.

Explore Treatment and Recovery Resources

Addiction Recovery Pro provides educational and informational resources. This article is not medical advice, diagnosis, treatment, legal advice or emergency assistance. Information may change after publication. Consult qualified professionals and original sources when making health, legal or treatment decisions.